Company news
Procept Biorobotics Corporation (NASDAQ:PRCT) news
Procept Biorobotics Corporation news releases on 6ix. Latest, Aug 17, 2026: PROCEPT BioRobotics® to Attend the Baird 2026 Global Healthcare Conference…
Press releases & updates
PROCEPT BioRobotics® to Attend the Baird 2026 Global Healthcare Conference on September 15, 2026
August 17, 2026
PROCEPT BioRobotics Reports Second Quarter 2026 Financial Results
August 4, 2026
PROCEPT BioRobotics® to Report Second Quarter 2026 Financial Results on August 4th, 2026
July 14, 2026
PROCEPT BioRobotics® Advances Prostate Cancer Program with WATER IV Study Enrollment Completion and Expanded IDE Approval
May 28, 2026
PROCEPT BioRobotics® to Attend Three Upcoming Investor Conferences in May & June
April 30, 2026
PROCEPT BioRobotics Reports First Quarter 2026 Financial Results
April 29, 2026
PROCEPT BioRobotics® to Report First Quarter 2026 Financial Results on April 29, 2026
April 9, 2026
Sonder Capital Closes its Second Fund and Announces Participation from Major Healthcare Systems
March 24, 2026
EAU Guidelines Upgrade Aquablation® Therapy to Strong Surgical Recommendation for BPH
March 22, 2026
PROCEPT BioRobotics® Announces International Launch of the HYDROS® Robotic System, Expanding Global Access to AI-Enabled Aquablation® Therapy
March 11, 2026
PROCEPT BioRobotics® Hosts 2026 Investor Day to Detail Multi-year Financial Outlook and Strategic Plan for Long-Term Growth
February 26, 2026
PROCEPT BioRobotics Reports Fourth Quarter 2025 Financial Results and Updates 2026 Revenue Guidance
February 25, 2026
PROCEPT BioRobotics® Announces Updated Dates for 4Q25 Earnings Conference Call and Investor Day
February 23, 2026
PROCEPT BioRobotics® to Attend the TD Cowen 46th Annual Health Care Conference and the 2026 Leerink Global Healthcare Conference
February 4, 2026
PROCEPT BioRobotics® to Host 4Q25 Earnings Conference Call on February 24, 2026, and Investor Day on February 25, 2026, in New York City
January 26, 2026
PROCEPT BioRobotics® to Present at Upcoming 37th Annual Piper Sandler Healthcare Conference on December 2, 2025
November 19, 2025
PROCEPT BioRobotics Reports Third Quarter 2025 Financial Results and Issues 2026 Revenue Guidance
November 3, 2025
PROCEPT BioRobotics® to Report Third Quarter 2025 Financial Results on November 4, 2025
October 14, 2025
PROCEPT BioRobotics Reports Second Quarter 2025 Financial Results and Increases 2025 Revenue Guidance
August 5, 2025
PROCEPT BioRobotics® President and CEO Dr. Reza Zadno to Retire, Company Appoints Larry L. Wood as New President and CEO
July 23, 2025
Ambulatory Surgery Center Completes WATER IV Trial Procedures for Prostate Cancer with Aquablation® Therapy
July 23, 2025
PROCEPT BioRobotics® to Report Second Quarter 2025 Financial Results on August 6, 2025
July 20, 2025
Aquablation® Therapy’s Assigned Category I Code in 2026 Medicare Proposed Physician Fee Schedule
July 13, 2025
PROCEPT BioRobotics® to Attend Four Upcoming Investor Conferences in May & June
April 28, 2025
PROCEPT BioRobotics Reports First Quarter 2025 Financial Results and Increases 2025 Revenue Guidance
April 23, 2025
PROCEPT BioRobotics' Aquablation Therapy Spotlighted at 2025 AUA Annual Meeting Along with Expert-Led Workshops
April 23, 2025
PROCEPT BioRobotics® Announces Investor Event at 2025 AUA Annual Meeting at the Aria Resort in Las Vegas
April 9, 2025
WATER III Randomized-Controlled Trial Results Announced at European Association of Urology Comparing Aquablation® Therapy to Laser Enucleation
March 23, 2025
PROCEPT BioRobotics® Announces Investor Event at 2025 AUA Annual Meeting in Las Vegas, Nevada
March 13, 2025
PROCEPT BioRobotics® Reports Fourth Quarter and Full Year 2024 Results
February 24, 2025
PROCEPT BioRobotics® to Report Fourth Quarter 2024 Financial Results on February 25, 2025 and Attend the TD Cowen 45th Annual Healthcare Conference and the 2025 Leerink Partners Healthcare Conference
February 6, 2025
PROCEPT BioRobotics to Present at Upcoming 36th Annual Piper Sandler Healthcare Conference on December 4, 2024
November 25, 2024
PROCEPT BioRobotics Corporation Announces Pricing of Offering of Common Stock
October 28, 2024
PROCEPT BioRobotics® Reports Third Quarter 2024 Financial Results and Increases 2024 Revenue and Adjusted EBITDA Guidance
October 27, 2024
PROCEPT BioRobotics Corporation Announces Proposed Offering of Common Stock
October 27, 2024
PROCEPT BioRobotics to Report Third Quarter 2024 Financial Results on October 28, 2024
October 8, 2024
PROCEPT BioRobotics Received U.S. FDA Approval to Initiate Pivotal Randomized Clinical Study for Prostate Cancer
October 6, 2024
PROCEPT BioRobotics to Present at Upcoming 2024 Wells Fargo Healthcare Conference on September 4, 2024
August 27, 2024
PROCEPT BioRobotics Announces FDA Clearance of the HYDROS™ Robotic System, the Next-Generation, AI-Powered Platform for Aquablation® Therapy
August 20, 2024
PROCEPT BioRobotics® Reports Second Quarter 2024 Financial Results and Increases 2024 Revenue and EBITDA Guidance
July 31, 2024
PROCEPT BioRobotics to Report Second Quarter 2024 Financial Results on August 1, 2024
July 14, 2024
PROCEPT BioRobotics Announces New CPT® Category I Code from the American Medical Association for Aquablation therapy
June 16, 2024
PROCEPT BioRobotics to Present at Upcoming 2024 Truist Securities MedTech Conference on June 18, 2024
June 2, 2024
PROCEPT BioRobotics to Present at Upcoming 2024 Leerink Partners Healthcare Crossroads Conference and 44th Annual William Blair Growth Stock Conference
May 12, 2024
Real-World, Long-Term Data Demonstrate Sustained Benefits of Aquablation Therapy for Men with Benign Prostatic Hyperplasia
May 5, 2024
PROCEPT BioRobotics Reports First Quarter 2024 Financial Results and Increases 2024 Revenue Guidance
April 30, 2024
Late Breaking Abstract Presented at the Japanese Urological Association Annual Meeting on Aquablation Therapy Outcomes for Men in Japan with Lower Urinary Tract Symptoms due to Benign Prostatic Hyperplasia
April 28, 2024
PROCEPT BioRobotics Announces 12 Scientific Research Presentations on Aquablation Therapy for the Treatment of Benign Prostatic Hyperplasia at the 2024 AUA Annual Meeting
April 22, 2024
PROCEPT BioRobotics Corp. Announces Investor Event at 2024 AUA Annual Meeting in San Antonio, Texas
April 3, 2024
PROCEPT BioRobotics to Report First Quarter 2024 Financial Results on May 1, 2024 and Attend the 2024 Bank of America Healthcare Conference on May 15, 2024
April 1, 2024